We have partnered with international experts to provide rare bone diseases highlights from ASBMR 2021.
This is the third episode in a series of four podcasts. In this episode Charlene Waldman (RBD Alliance) and Inês Alves (European Rare Bone Forum) discuss their highlights.
We have partnered with international experts to provide rare bone diseases highlights from ASBMR 2021. This is the second in a series of four...
How are advances in radioligand therapy shaping the treatment of neuroendocrine tumours, and what does recent trial evidence tell us? What are the key...
We have partnered with international experts to provide rare bone disease highlights from ASBMR 2021. This is the first episode in a series of...